The purpose of this study is to evaluate the efficacy of Combined Intravesical Therapy With Hyaluronic Acid and Chondroitin Sulphate in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract
The purpose of this study is to evaluate the efficacy of combined intravesical therapy with hyaluronic acid and chondroitin sulphate(IARULIL®) in the treatment of recurrent cystitis refractory to oral Escherichia Coli extract(Uro-Vaxom®) and the change of urinary tract infection symptoms after intravesical instillation treatment with IARULIL®.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
105
IALURIL Intravesical instillation with cystoscope ( 1st month: once a week, 2nd\~5th month:once a month)
Samsung Medical Center
Seoul, South Korea
The number of recurrence for recurrent cystitis
Time frame: 12 months
Time interval of cystitis
Time frame: 12months
The score change of UTI symptom Assessment questionnaire(UTISA)
Time frame: 12months
Global Respone assessment(GRA) score assessment
Time frame: 12 month after treatment
safety evaluation Safety evaluation
Time frame: 12 month after treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.